Adenine derived inhibitors of the molecular chaperone HSP90—SAR explained through multiple X-ray structures
- 11 December 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (2) , 325-328
- https://doi.org/10.1016/j.bmcl.2003.11.011
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Crystal Structure and Molecular Modeling of 17-DMAG in Complex with Human Hsp90Chemistry & Biology, 2003
- Role of the retinoblastoma protein in differentiation and senescence.Cancer Biology & Therapy, 2003
- Development of a Purine-Scaffold Novel Class of Hsp90 Binders that Inhibit the Proliferation of Cancer Cells and Induce the Degradation of Her2 Tyrosine KinaseBioorganic & Medicinal Chemistry, 2002
- Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD 2 F 1 mice and Fischer 344 ratsCancer Chemotherapy and Pharmacology, 2002
- Stereospecific antitumor activity of radicicol oxime derivativesCancer Chemotherapy and Pharmacology, 2001
- Hsp90The Journal of cell biology, 2001
- A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cellsChemistry & Biology, 2001
- Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1Cancer Chemotherapy and Pharmacology, 2001
- Structure and in vivo function of Hsp90Current Opinion in Structural Biology, 2000
- Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and GeldanamycinJournal of Medicinal Chemistry, 1999